Table 1.

Demographic and clinical characteristics of study participants (n = 331)

Clinical characteristics
Gender n (%)
Male	167 (50.5%)
Female	164 (49.5%)
Ethnicity n (%)
African	261 (78.8%)
Indian	28 (8.5%)
White	32 (9.7%)
Coloured	10 (3%)
Age (years) mean ± SD	35.2 ± 11.98
Age distribution n (%)
18-30 years	141 (42.6%)
31-40 years	82 (24.8%)
41-50 years	60 (18.1%)
51-64 years	48 (14.5%)
Employment n (%)
Unemployed	200 (60.4%)
Formal	32 (9.7%)
Student	36 (10.9%)
Disability grant/old age pension	63 (19%)
Diagnosis n (%)
Schizophrenia	163 (49.3%)
Major Depressive Disorder	15 (4.5%)
Bipolar Mood Disorder	49 (14.8%)
Schizoaffective Disorder	36 (10.9%)
Mood/psychotic disorder due to a general medical condition	68 (20.5%)
Antipsychotic- medications n (%)
Risperidone	125(37.8%)
Chlorpromazine	37 (11.2%)
Haloperidol	54 (16.3%)
Zuclopenthixol Decanoate	19 (5.8%)
Clozapine	15 (4.5%)
Olanzapine	13 (3.9%)
Quetiapine	45 (13.6%)
Amisulpride	12 (3.6%)
Aripiprazole	11 (3.3%)
History of [n (%)]:
Smoking	77 (23.3%)
HIV disease	67 (20.2%)
Hypertension	12 (3.6%)
Type 2 diabetes	5 (1.5%)

Results expressed as n (%) or mean ± SD.